doi:10.3969/j.issn.1004-583X.2022.11.015

Abstract

CLC Number:

R589.2

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2022.11.015

https://huicui.hebmu.edu.cn/EN/Y2022/V37/I11/1044

References 36

[1]	Baker RG, Hayden MS, Ghosh S. NF-κB, inflammation, and metabolic disease[J]. Cell Metab, 2011, 13(1):11-22. doi: 10.1016/j.cmet.2010.12.008 pmid: 21195345
[2]	Lee YS, Olefsky J. Chronic tissue inflammation and metabolic disease[J]. Genes Dev, 2021, 35(5-6): 307-328. doi: 10.1101/gad.346312.120 URL
[3]	Kosekli MA, Kurtkulagii O, Kahveci G, et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: The abund study[J]. Rev Assoc Med Bras, 2021, 67(4): 549-554. doi: 10.1590/1806-9282.20201005 pmid: 34495059
[4]	Cao W, Zheng RD, Xu SH, et al. Association between sex hormone and blood uric acid in male patients with type 2 diabetes[J]. Int J Endocrinol, 2017, 2017: 4375253.
[5]	中华医学会内分泌学分会. 中国高尿酸血症与痛风诊疗指南(2019)[J]. 中华内分泌代谢杂志, 2020, 36(1): 1-13.
[6]	George J, Struthers AD. Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress[J]. Vasc Health Risk Man, 2009, 5(1): 265-272.
[7]	Borghi C, Agnoletti D, Cicero AFG, et al. Uric acid and hypertension: A review of evidence and future perspectives for the management of cardiovascular risk[J]. Hypertension, 2022, 79(9): 1927-1936. doi: 10.1161/HYPERTENSIONAHA.122.17956 pmid: 35658505
[8]	Copur S, Demiray A, Kanbay M. Uric acid in metabolic syndrome: Does uric acid have a definitive role?[J]. Eur J Intern Med, 2022, 103(9): 4-12. doi: 10.1016/j.ejim.2022.04.022 URL
[9]	Hwang J, Lee MY, Ahn JK, et al. Relationship between changing body mass index and serum uric acid alteration among clinically apparently healthy Korean men[J]. Arthrit Care Res, 2022, 74(8): 1277-1286. doi: 10.1002/acr.24576 URL
[10]	Yan P, Zhang Z, Wan Q, et al. Association of serum uric acid with bone mineral density and clinical fractures in Chinese type 2 diabetes mellitus patients: A cross-sectional study[J]. Clin Chim Acta, 2018, 486(11): 76-85. doi: 10.1016/j.cca.2018.07.033 URL
[11]	Yang S, Ye Z, Liu M, et al. Association of serum uric acid with all-cause and cardiovascular mortality among adults with nonalcoholic fatty liver disease[J]. Clin Endocrinol, 2022, 98(1): 49-58. doi: 10.1111/cen.14810 URL
[12]	Van der vorst EPC. High-density lipoproteins and apolipoprotein A1[J]. Subcell Biochem, 2020, 94: 399-420. doi: 10.1007/978-3-030-41769-7_16 pmid: 32189309
[13]	Aktas G, Kocak MZ, Bilgin S, et al. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus[J]. Aging Male, 2020, 23(5): 1098-1102. doi: 10.1080/13685538.2019.1678126 URL
[14]	Nathan DM, Zinman B, Cleary PA, et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: The diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005)[J]. Arch Intern Med, 2009, 169(14): 1307-1316. doi: 10.1001/archinternmed.2009.193 pmid: 19636033
[15]	Kowalski AJ, Dutta S. It's time to move from the A1c to better metrics for diabetes control[J]. Diabetes Technol Ther, 2013, 15(3): 194-196. doi: 10.1089/dia.2013.0060 URL
[16]	尤玉青, 李伟, 周东浩. 血尿酸/高密度脂蛋白胆固醇比值与糖尿病肾脏疾病的相关性研究[J]. 中国糖尿病杂志, 2021, 29(10): 749-753.
[17]	Cheung N, Mitchell P, Wong TY. Diabetic retinopathy[J]. Lancet, 2010, 376(9735): 124-136. doi: 10.1016/S0140-6736(09)62124-3 pmid: 20580421
[18]	Cipriani C, Colangelo L, Santori R, et al. The interplay between bone and glucose metabolism[J]. Front Endocrinol (Lausanne), 2020, 11(24): 122. doi: 10.3389/fendo.2020.00122 URL
[19]	Dhawan S, Natarajan R. Epigenetics and type 2 diabetes risk[J]. Curr Diabetes Rep, 2019, 19(8): 47. doi: 10.1007/s11892-019-1168-8 pmid: 31250127
[20]	Zhang Q, Zhou J, Wang Q, et al. Association between bone mineral density and lipid profile in Chinese women[J]. Clin Interv Aging, 2020, 15(15):1649-1664. doi: 10.2147/CIA.S266722 URL
[21]	Niu P, Li H, Liu D, et al. Association between HDL-C and bone mineral density: An cross-sectional analysis[J]. Int J Gen Med, 2021, 14(26): 8863-8872. doi: 10.2147/IJGM.S334972 URL
[22]	Tang Y, Wang S, Yi Q, et al. High-density lipoprotein cholesterol is negatively correlated with bone mineral density and has potential predictive value for bone loss[J]. Lipids Health Dis, 2021, 20(1): 75. doi: 10.1186/s12944-021-01497-7 pmid: 34304735
[23]	相爱霞, 宋勇刚, 于婷婷, 等. 2型糖尿病血清尿酸与高密度脂蛋白比值和骨代谢、骨密度和骨质疏松的相关研究[J]. 糖尿病新世界, 2022, 25(12): 26-30.
[24]	Chen YY, Kao TW, Yang HF, et al. The association of uric acid with the risk of metabolic syndrome, arterial hypertension or diabetes in young subjects- An observational study[J]. Clin Chim Acta, 2018, 478: 68-73. doi: 10.1016/j.cca.2017.12.038 URL
[25]	Kocak MZ, Aktas G, Erkus E, et al. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus[J]. Rev Assoc Med Bras(1992), 2019, 65(1): 9-15.
[26]	Yazdi F, Baghaei MH, Baniasad A, et al. Investigating the relationship between serum uric acid to high-density lipoprotein ratio and metabolic syndrome[J]. Endocrinol Diabetes Metab, 2022, 5(1): e00311.
[27]	中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018年更新版)[J]. 实用肝脏病杂志, 2018, 21(2): 177-186.
[28]	Hijona E, Hijona L, Arenas JI, et al. Inflammatory mediators of hepatic steatosis[J]. Mediat Inflamm, 2010, 2010: 837419.
[29]	Zhang YN, Wang QQ, Chen YS, et al. Association between serum uric acid to HDL-cholesterol ratio and nonalcoholic fatty liver disease in lean Chinese adults[J]. Int J Endocrinol, 2020, 2020: 5953461.
[30]	Sagris M, Antonopoulos AS, Theofilis P, et al. Risk factors profile of young and older patients with myocardial infarction[J]. Cardiovasc Res, 2022, 118(10): 2281-2292. doi: 10.1093/cvr/cvab264 URL
[31]	Park B, Jung DH, Lee YJ. Predictive value of serum uric acid to HDL cholesterol ratio for incident ischemic heart disease in non-diabetic Koreans[J]. Biomedicines, 2022, 10(6): 1422. doi: 10.3390/biomedicines10061422 URL
[32]	Antonelli A, Ferrari SM, Corrado A, et al. Autoimmune thyroid disorders[J]. Autoimmun Rev, 2015, 14(2): 174-180. doi: 10.1016/j.autrev.2014.10.016 pmid: 25461470
[33]	Volpé R. The pathology of thyroiditis[J]. Hum Pathol, 1978, 9(4): 429-438. pmid: 581380
[34]	Vukovic R, Zeljkovic A, Bufan B, et al. Hashimoto thyroiditis and dyslipidemia in childhood: A review[J]. Front Endocrinol (Lausanne), 2019, 10(10): 868. doi: 10.3389/fendo.2019.00868 URL
[35]	Kurtkulagi O, Tel BMA, Kahveci G, et al. Hashimoto's thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio[J]. Rom J Intern Med, 2021, 59(4): 403-408. doi: 10.2478/rjim-2021-0023 pmid: 34142519
[36]	Aktas G, Khalid A, Kurtkulagi O, et al. Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: A cross-sectional cohort study[J]. Postgrad Med, 2022, 134(3): 297-302. doi: 10.1080/00325481.2022.2039007 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 36

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Han Tuo, Wang Lixia, Wang Yiwen, Li Ying, Gong Hong, Zhang Chunyan, Zhang Yan, Li Yongqin, Wang Congxia. Correlation analysis between dietary nutrient intake with blood glucose and insulin resistance in healthy population [J]. Clinical Focus, 2023, 38(2): 126-131.
[2]	Zhang Shu, Bao Yun, Chen Fang, Shan Qing. Predictive value of body composition and anthropometry for dyslipidemia in postmenopausal women [J]. Clinical Focus, 2022, 37(8): 708-712.
[3]	. [J]. Clinical Focus, 2022, 37(7): 658-662.
[4]	. [J]. Clinical Focus, 2022, 37(5): 477-480.
[5]	Yang Peilong;Wang Lixin;Yuan Fang;Gao Jinchai. Rosuvastatin on inflammatory cytokines and ankle-brachial index in mild-moderate hypertensive patients with hyperlipemia [J]. Clinical Focus, 2015, 30(12): 1363-1366.
[6]	Peng Fang;Peng Jiahao;Ji Zheng;Tang Weilang. Effect of Salvia safflower extract on ventricular remodel after acute myocardial infarction [J]. Clinical Focus, 2015, 30(6): 609-612.
[7]	Zhao Xiumin. Efficacy and safety of Zhikang granule combined with atorvastatin in treatment of hyperlipidemia [J]. Clinical Focus, 2015, 30(3): 268-271272.
[8]	. [J]. CLINICAL FOCUS, 2013, 28(11): 1312-1315.
[9]	. [J]. Clinical Focus, 2013, 28(2): 234-236.
[10]	. [J]. Clinical Focus, 2012, 27(23): 2103-2108.
[11]	. [J]. Clinical Focus, 2012, 27(22): 1970-1971.
[12]	. [J]. Clinical Focus, 2012, 27(17): 1562-1564.
[13]	. [J]. Clinical Focus, 2012, 27(14): 1235-1237.
[14]	. [J]. Clinical Focus, 2012, 27(10): 872-874.
[15]	WANG Bao-dong;TAN Xiao-hua;YANG Lei. Cholesteryl ester transfer protein rs3764261 effect on lipid levels in Han Chinese population [J]. Clinical Focus, 2012, 27(5): 390-392.